Fighting Blindness Canada Archives

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

Wednesday, December 11 2024 | 10 h 01 min | News

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet...

Canada’s Vision Health Stakeholders Applaud Parliament’s Passage of Bill C-284, the National Strategy for Eye Care Act

Monday, November 18 2024 | 14 h 57 min | News

The recent passage of Bill C-284, the National Strategy for Eye Care Act by the Government of Canada, marks a significant advancement in the...

Robotic Radiation Treatment May Help Treat Wet AMD

Wednesday, October 16 2024 | 13 h 46 min | Vision Science

A new study, published in The Lancet, suggests that a one-time radiation therapy may reduce the number of anti-VEGF injections needed for wet...

First Patients Treated in XLRP Gene Therapy Trial

Tuesday, September 17 2024 | 14 h 31 min | Vision Science

Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked...

New Gene Replacement Clinical Trial Launched for RP Test

Tuesday, September 3 2024 | 08 h 46 min | Vision Science & Research

ViGeneron in Munich, Germany has launched a new Phase 1b clinical trial testing a novel gene replacement therapy in individuals affected by...

1 2 3 … 6 Next »

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

Vision Expo East 2025 will offer new conference programming for professional development in the eyecare and eyewear industry, offering over 270 hours of accredited and non-accredited education tailored to the needs of ophthalmologists, optometrists, opticians and allied professionals.

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Tag: Fighting Blindness Canada

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

Canada’s Vision Health Stakeholders Applaud Parliament’s Passage of Bill C-284, the National Strategy for Eye Care Act

Robotic Radiation Treatment May Help Treat Wet AMD

First Patients Treated in XLRP Gene Therapy Trial

New Gene Replacement Clinical Trial Launched for RP Test

Featured Posts

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025